| Richard Wurtzel, | |
|
100 York St Apt 14d, New Haven, CT 06511-5609 | |
| (203) 605-7229 | |
| Not Available |
| Full Name | Richard Wurtzel |
|---|---|
| Gender | Male |
| Speciality | Speech-language Pathologist |
| Location | 100 York St Apt 14d, New Haven, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083099238 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 002770 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Richard Wurtzel, 100 York St Apt 14d, New Haven, CT 06511-5609 Ph: () - | Richard Wurtzel, 100 York St Apt 14d, New Haven, CT 06511-5609 Ph: (203) 605-7229 |
News Archive
Intellect Neurosciences, Inc., a biopharmaceutical company focused on development of disease-modifying therapeutic agents for Alzheimer's disease, announced today it has completed a restructuring of its balance sheet. The result is the extinguishment of approximately $24 million of aggregate face amount plus accrued interest of debt and preferred stock through the issuance of common stock.
NASA hopes to send humans to Mars by 2030 on a round-trip mission that could take up to three years - far longer than any human has ever traveled in space.
How can an active principle be delivered in a controlled way? Until now, there was no obvious answer to this question. Now however, researchers at the CNRS Paul Pascal Research Center in Bordeaux have designed smart capsules that are able to release their contents on demand, simply by raising the temperature. Described in an article published on 2 February 2010 in the journal Langmuir, this novel system has just been patented. It opens up the way to many applications in a large number of fields such as food, perfumes and agriculture, for instance to deliver pesticides above a specific temperature.
ProtAffin AG, a biotechnology company developing a novel class of biopharmaceutical products that act by targeting cell-surface glycan structures, today presents compelling preclinical data in chronic obstructive pulmonary disease (COPD) for its lead product PA401 at the European Respiratory Society Congress in Barcelona, Spain. This conference is the largest gathering of scientists and clinicians in the respiratory community in the world. The Oral Presentation will be made in the session "Pre-clinical models of airways disease".
Well over six million people globally have been diagnosed with Parkinson's disease, which has an enormous impact on the lives of patients and their families and incurring mounting costs for society.
› Verified 2 days ago
Ruchi Chandrakant Rana, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 20 York St, New Haven, CT 06510 Phone: 203-512-8951 | |
Rachel Wiberg, SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 335 Orange St Apt 501, New Haven, CT 06511 Phone: 203-470-3249 | |
Lynn M Acton, MS Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 800 Howard Ave, Yale Physicians Building-4th Fl, New Haven, CT 06519 Phone: 203-785-2593 Fax: 203-785-5936 | |
Aleeza Sarah Zeiger, Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 122 Hubinger St Fl 3, New Haven, CT 06511 Phone: 203-232-3069 | |
John Patrick Gerrity Jr., MA, CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 800 Howard Ave Fl 4, New Haven, CT 06519 Phone: 203-785-5430 | |
Eva Montas, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 118 Clinton Ave, New Haven, CT 06513 Phone: 860-840-0861 |